Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

soda, sugar-sweetened beverages

Taxes on sugar-sweetened beverages work

Philadelphia's new tax led to a significant decline in the purchase of sugar-sweetened beverages such as soft drinks and lemonade, according to new data published in JAMA Network Open. The ACC, AHA, CDC and other organizations have all recommended against drinking too many of these beverages.

covid-19 mask temperature check

Evidence of COVID-19 surfaced here much sooner than thought

A new study has revealed that COVID-19 was likely already spreading in the U.S. much earlier than previously reported. In fact, the study adds to the CDC’s study suggesting the virus was present here as early as December 2019.

 

Thumbnail

TEER with MitraClip XTR leads to consistent TR reduction, outperforming older devices

Researchers reported a technical success rate of 100%, but they did urge caution if the patient's coaptation gap size exceeds 8.4 mm. 

Thumbnail

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

Thumbnail

Heart failure patients see long-term benefits after cell therapy

"This is a very important advance in the field of cell therapy and in the management of heart failure," one specialist said. 

Thumbnail

Vermont drops all COVID-19 restrictions after reaching 80% vaccination rate

Vermont is ahead of the vaccination curve compared to the rest of the United States. 

 

AFib patients are missing out on the care they need

The study, published in JACC: Clinical Electrophysiology, included data from more than 3,000 patients. 

Better Together? An Integrated Market for Calcium-modification Strategies

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. That, in fact, is already occurring. One strategy gaining currency among interventionalists, particularly those in Europe, is to try a high-pressure balloon first in cases of moderately severe calcification and, if the device fails to fully expand, re-enter the vessel with atherectomy.